OTTAWA—Health Canada is demanding that AstraZeneca do a detailed study on the risks and benefits of its COVID-19 vaccine across multiple age groups after getting more reports that patients in Europe developed blood clots following vaccination. The agency says it has not received any reports of blood clots in Canada to date. The regulators that…